Triglav Investments D.O.O. Purchases 12,700 Shares of Danaher Corporation $DHR

Triglav Investments D.O.O. lifted its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 211.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,700 shares of the conglomerate’s stock after purchasing an additional 12,700 shares during the period. Triglav Investments D.O.O.’s holdings in Danaher were worth $4,281,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Viking Global Investors LP grew its stake in Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after buying an additional 2,455,994 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in shares of Danaher by 104.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock valued at $991,923,000 after purchasing an additional 2,216,789 shares in the last quarter. Generation Investment Management LLP lifted its holdings in shares of Danaher by 34.0% during the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after acquiring an additional 1,689,020 shares during the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Danaher by 211.7% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,088,089 shares of the conglomerate’s stock worth $414,038,000 after acquiring an additional 1,418,243 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in shares of Danaher by 33.9% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 3,519,013 shares of the conglomerate’s stock worth $697,680,000 after acquiring an additional 891,210 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent research reports. Citigroup began coverage on shares of Danaher in a research note on Tuesday. They issued a “buy” rating and a $230.00 price target for the company. TD Cowen reduced their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Evercore upped their price objective on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a report on Tuesday, April 21st. Guggenheim cut their price objective on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Finally, Wolfe Research dropped their target price on shares of Danaher from $260.00 to $230.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 8th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $238.24.

Check Out Our Latest Stock Report on Danaher

Danaher Price Performance

DHR stock opened at $182.73 on Friday. The company has a fifty day simple moving average of $182.11 and a two-hundred day simple moving average of $207.48. The firm has a market capitalization of $129.33 billion, a P/E ratio of 35.34, a price-to-earnings-growth ratio of 2.41 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.88 earnings per share. Analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is 30.95%.

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.